Results 181 to 190 of about 231,408 (231)

Family planning in the Atwima Nwabiagya North District: A follow-up on attitudes and practices. [PDF]

J Public Health Afr
Henrie AJ, Atobiloye M, Radmall B, Sorensen QN, Yanagihara A, Ansong D, Sarpong E, Benson LS, Dickerson T.   +8 more
europepmc   +1 more source

Women's experiences with and preferences for contraceptive side effect counseling and management: A qualitative study from Ethiopia and Kenya. [PDF]

PLoS One
Suchman L, Phillips B, Gitome S, Bizuneh H, Feleke H, Kwena Z, Okumu S, Wekesa P, Bukusi EA, Kirksey K, Holt K, Liu J, Gebrehanna E.   +12 more
europepmc   +1 more source

Prevalence, Method Mix, and Determinants of Contraceptive Use Among Eligible Couples in an Urban Resettlement Colony of Delhi. [PDF]

Cureus
Bangla S, Rai S, Yadav K, Nongkynrih B.
europepmc   +1 more source

Socio-behavioral factors linked to willingness to use new male contraceptives: A cross-sectional survey of men and female partners across four low- and middle-income countries.

Contraception
Nguyen BT, Kidula N, Kapp N, Nosirov K, Ali MM, Maamri A, Manu KA, Boateng KA, Sánchez M, Montenegro PC, Dzotsi KE, Kiarie J.   +11 more
europepmc   +1 more source

Exploring the determinants of family planning practices among women with diabetes and no pregnancy intention in Malaysia: women's voices. [PDF]

Korean J Fam Med
Ismail IZ, Ng CJ, Lee PY, Hussein N.
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Withdrawal users’ perceptions of and experience with contraceptive methods in Manisa, Turkey

Midwifery, 2006
To gain an understanding of the knowledge, perceptions and experiences of using contraceptive methods among Turkish withdrawal users.Population-based, cross-sectional and descriptive study using a questionnaire conducted face to face.Women who live in the Number 6 primary health unit area in Manisa, Turkey.276 women who used the 'withdrawal' method for
Emre Yanıkkerem, Emel Elem
exaly   +3 more sources

Hormone withdrawal symptoms in oral contraceptive users

Obstetrics & Gynecology, 2000
To measure the timing, frequency, and severity of hormone-related symptoms in oral contraceptive (OC) users, specifically to compare active-pill with hormone-free intervals.Using daily diaries, women recorded pelvic pain, bleeding, headaches, analgesic use, nausea or vomiting, bloating or swelling, and breast tenderness during active-pill intervals and
P J, Sulak, R D, Scow, C, Preece, M W, Riggs, T J, Kuehl   +4 more
openaire   +2 more sources

Rapid Disappearance of Hepatic Adenoma After Contraceptive Withdrawal

Journal of Clinical Gastroenterology, 2001
We present the case of a 25-year-old woman who developed a large central liver adenoma after 8 years of continuous oral contraceptive use. The first diagnosis was made by ultrasonography, after a rise in plasmatic gamma-glutamyl-transpeptidase and alkaline phosphatase levels was noted.
P. Aseni, C. V. Sansalone, C. Sammartino, F. Di Benedetto, G. Carrafiello, A. Giacomoni, C. Osio, M. Vertemati, D. Forti   +8 more
openaire   +4 more sources

Suppression of estrogen-withdrawal headache with extended transdermal contraception

Fertility and Sterility, 2005
A randomized clinical trial was conducted with 239 women at nine clinical research sites to compare bleeding profile, headache frequency, and subject satisfaction with the transdermal contraceptive, ORTHO EVRA (norelgestromin/ethinyl estradiol transdermal system) used in an extended regimen (84 days) with a traditional, 28-day cyclic regimen.
Katherine D, LaGuardia, Alan C, Fisher, James D, Bainbridge, John M, LoCoco, Andrew J, Friedman   +4 more
openaire   +2 more sources